CN105744940A - 葡糖胺聚糖的羧基化衍生物以及作为药物的用途 - Google Patents
葡糖胺聚糖的羧基化衍生物以及作为药物的用途 Download PDFInfo
- Publication number
- CN105744940A CN105744940A CN201480063192.9A CN201480063192A CN105744940A CN 105744940 A CN105744940 A CN 105744940A CN 201480063192 A CN201480063192 A CN 201480063192A CN 105744940 A CN105744940 A CN 105744940A
- Authority
- CN
- China
- Prior art keywords
- glucosaminoglycan
- heparin
- oxidation
- heparanase
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
对应于残基位置的信号 | 1H ppm | 13C ppm |
C5-糖醛酸gsox | 4.97 | 81.65 |
C4-糖醛酸gsox | 4.59 | 81.22 |
C1-糖醛酸gsox | 5.01 | 103.71 |
C4 | 3.63 | 79.14 |
C1-葡糖胺NS(ANS) | 5.40 | 99.17 |
C1-ANS连接至(gsox) | 5.03 | 100.19 |
C1-艾杜糖醛酸2S | 5.17 | 102.11 |
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910539702.XA CN110218268B (zh) | 2013-11-06 | 2014-10-22 | 糖胺聚糖的羧基化衍生物以及作为药物的用途 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000006A ITLO20130006A1 (it) | 2013-11-06 | 2013-11-06 | Derivati carbossilati di glucosamminoglicani e loro uso come farmaci |
ITLO2013A000006 | 2013-11-06 | ||
PCT/EP2014/072676 WO2015067471A1 (en) | 2013-11-06 | 2014-10-22 | Carboxylated derivatives of glucosaminoglycans and use as drugs |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910539702.XA Division CN110218268B (zh) | 2013-11-06 | 2014-10-22 | 糖胺聚糖的羧基化衍生物以及作为药物的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105744940A true CN105744940A (zh) | 2016-07-06 |
CN105744940B CN105744940B (zh) | 2019-06-25 |
Family
ID=49683858
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910539702.XA Active CN110218268B (zh) | 2013-11-06 | 2014-10-22 | 糖胺聚糖的羧基化衍生物以及作为药物的用途 |
CN201480063192.9A Active CN105744940B (zh) | 2013-11-06 | 2014-10-22 | 糖胺聚糖的羧基化衍生物以及作为药物的用途 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910539702.XA Active CN110218268B (zh) | 2013-11-06 | 2014-10-22 | 糖胺聚糖的羧基化衍生物以及作为药物的用途 |
Country Status (14)
Country | Link |
---|---|
US (3) | US10822430B2 (zh) |
EP (3) | EP3520797B1 (zh) |
JP (1) | JP6784454B2 (zh) |
KR (1) | KR102113905B1 (zh) |
CN (2) | CN110218268B (zh) |
CY (2) | CY1120221T1 (zh) |
DK (3) | DK3308791T3 (zh) |
ES (3) | ES2660777T3 (zh) |
HK (1) | HK1222797A1 (zh) |
IT (1) | ITLO20130006A1 (zh) |
PL (3) | PL3065747T3 (zh) |
PT (3) | PT3520797T (zh) |
TR (2) | TR201906180T4 (zh) |
WO (1) | WO2015067471A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019149179A1 (zh) * | 2018-02-02 | 2019-08-08 | 深圳市海普瑞药业集团股份有限公司 | 糖胺聚糖衍生物及其制备方法和用途 |
WO2022143853A1 (zh) | 2020-12-31 | 2022-07-07 | 深圳市海普瑞药业集团股份有限公司 | 一种用于检测样品中糖胺聚糖羧酸化衍生物含量的方法及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1295666A (zh) * | 1969-06-17 | 1972-11-08 | ||
CA928218A (en) * | 1969-06-17 | 1973-06-12 | Recherche Et Industrie Therapeutiques R.I.T. | Antiinfectious compositions and process for their preparation |
IT1230582B (it) | 1988-10-21 | 1991-10-28 | Opocrin S P A Lab Farmabiologi | Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica |
SE466779B (sv) | 1991-02-13 | 1992-03-30 | L T S I Soederkoeping Ab | Anordning vid ett kylsystem foer kylning av teleteknisk utrustning |
US5250519A (en) | 1991-03-29 | 1993-10-05 | Glycomed Incorporated | Non-anticoagulant heparin derivatives |
IL131074A0 (en) * | 1999-07-23 | 2001-03-19 | Polygene Ltd | A biodegradable polycation composition for delivery of an anionic macromolecule |
IT1316986B1 (it) * | 2000-01-25 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica. |
US7781416B2 (en) | 2000-01-25 | 2010-08-24 | Sigma-Tau Research Switzerland S.A. | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
US20020062019A1 (en) * | 2000-03-30 | 2002-05-23 | Pasqua Oreste | Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
ATE511846T1 (de) * | 2001-09-12 | 2011-06-15 | Sigma Tau Res Switzerland Sa | Derivate von teildesulfatierten glycosaminoglycanen als inhibitoren von heparanase, mit antiangiogener wirkung und ohne antikoagulatorische wirkung |
WO2009059283A1 (en) * | 2007-11-02 | 2009-05-07 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
-
2013
- 2013-11-06 IT IT000006A patent/ITLO20130006A1/it unknown
-
2014
- 2014-10-22 DK DK17205232.6T patent/DK3308791T3/en active
- 2014-10-22 CN CN201910539702.XA patent/CN110218268B/zh active Active
- 2014-10-22 ES ES14790560.8T patent/ES2660777T3/es active Active
- 2014-10-22 ES ES17205232T patent/ES2724475T3/es active Active
- 2014-10-22 KR KR1020167014561A patent/KR102113905B1/ko active IP Right Grant
- 2014-10-22 DK DK14790560.8T patent/DK3065747T3/en active
- 2014-10-22 JP JP2016550977A patent/JP6784454B2/ja active Active
- 2014-10-22 PL PL14790560T patent/PL3065747T3/pl unknown
- 2014-10-22 WO PCT/EP2014/072676 patent/WO2015067471A1/en active Application Filing
- 2014-10-22 US US15/034,555 patent/US10822430B2/en active Active
- 2014-10-22 PT PT191649540T patent/PT3520797T/pt unknown
- 2014-10-22 PT PT147905608T patent/PT3065747T/pt unknown
- 2014-10-22 TR TR2019/06180T patent/TR201906180T4/tr unknown
- 2014-10-22 EP EP19164954.0A patent/EP3520797B1/en active Active
- 2014-10-22 DK DK19164954.0T patent/DK3520797T3/da active
- 2014-10-22 EP EP17205232.6A patent/EP3308791B1/en active Active
- 2014-10-22 TR TR2018/02314T patent/TR201802314T4/tr unknown
- 2014-10-22 CN CN201480063192.9A patent/CN105744940B/zh active Active
- 2014-10-22 PL PL17205232T patent/PL3308791T3/pl unknown
- 2014-10-22 EP EP14790560.8A patent/EP3065747B1/en active Active
- 2014-10-22 PL PL19164954T patent/PL3520797T3/pl unknown
- 2014-10-22 PT PT17205232T patent/PT3308791T/pt unknown
- 2014-10-22 ES ES19164954T patent/ES2835173T3/es active Active
-
2016
- 2016-09-20 HK HK16111020.3A patent/HK1222797A1/zh unknown
-
2018
- 2018-02-23 CY CY20181100223T patent/CY1120221T1/el unknown
-
2019
- 2019-04-24 CY CY20191100449T patent/CY1121569T1/el unknown
-
2020
- 2020-02-04 US US16/781,735 patent/US11332548B2/en active Active
- 2020-02-21 US US16/798,065 patent/US11370848B2/en active Active
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019149179A1 (zh) * | 2018-02-02 | 2019-08-08 | 深圳市海普瑞药业集团股份有限公司 | 糖胺聚糖衍生物及其制备方法和用途 |
CN111670038A (zh) * | 2018-02-02 | 2020-09-15 | 深圳市海普瑞药业集团股份有限公司 | 糖胺聚糖衍生物及其制备方法和用途 |
US11225531B2 (en) | 2018-02-02 | 2022-01-18 | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | Glycosaminoglycan derivative and preparation method therefor and use thereof |
CN111670038B (zh) * | 2018-02-02 | 2024-01-26 | 深圳市海普瑞药业集团股份有限公司 | 糖胺聚糖衍生物及其制备方法和用途 |
WO2022143853A1 (zh) | 2020-12-31 | 2022-07-07 | 深圳市海普瑞药业集团股份有限公司 | 一种用于检测样品中糖胺聚糖羧酸化衍生物含量的方法及其应用 |
TWI807565B (zh) * | 2020-12-31 | 2023-07-01 | 大陸商深圳市海普瑞藥業集團股份有限公司 | 一種用於檢測樣品中醣胺聚醣羧酸化衍生物含量的方法及其應用 |
CN116710772A (zh) * | 2020-12-31 | 2023-09-05 | 深圳市海普瑞药业集团股份有限公司 | 一种用于检测样品中糖胺聚糖羧酸化衍生物含量的方法及其应用 |
CN116710772B (zh) * | 2020-12-31 | 2024-04-02 | 深圳市海普瑞药业集团股份有限公司 | 一种用于检测样品中糖胺聚糖羧酸化衍生物含量的方法及其应用 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210054108A2 (en) | Derivatives of n-desulfated glycosaminoglycans and use as drigs | |
US11370848B2 (en) | Carboxylated derivatives of glycosaminoglycans and use as drugs | |
Zhang et al. | Purification, chemical analysis and inhibitory effects on galectin-3 of enzymatic pH-modified citrus pectin | |
Li | Study of the biological functions of chemically modified glycosaminoglycan derivatives as potential therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160810 Address after: Delaware Applicant after: Nova health Biological Systems Ltd Address before: Milan Italy Applicant before: "G. Longzoni" S.R. biochemical high-tech research center |
|
CB02 | Change of applicant information |
Address after: The United States Wisconsin Applicant after: Nova health Biological Systems Ltd Address before: Delaware Applicant before: Nova health Biological Systems Ltd |
|
COR | Change of bibliographic data | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1222797 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant |